Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less

被引:56
作者
Kobayashi, Naruyuki
Toyooka, Shinichi
Soh, Junichi
Ichimura, Kouichi
Yanai, Hiroyuki
Suehisa, Hiroshi
Ichihara, Shuji
Yamane, Masaomi
Aoe, Motoi
Sano, Yoshifumi
Date, Hiroshi
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Canc & Thorac Surg, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008558, Japan
关键词
non-small cell lung cancer; stage I; tumor diameter of <= 20 mm; prognostic factor; histologic grade;
D O I
10.1097/JTO.0b013e31814617c7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of this study was to identify risk factors for disease recurrence and unfavorable prognosis after surgical resection for stage I non-small cell lung cancer in patients with tumor diameters of <= 20 mm. Methods: One hundred sixty-three patients who had pathologic stage I non-small cell lung cancer with tumor diameters <= 20 mm and who had undergone a lobectomy with mediastinal lymph node dissection were retrospectively reviewed. The relationships between clinicopathologic factors and clinical outcomes, including recurrence and survival, were then examined. The clinicopathologic factors examined in this study were age, sex, smoking status, preoperative serum carcinoembryonic antigen level, pathologic tumor size, histologic subtype, histologic grade, and visceral pleural invasion. Results: Among the clinicopathologic factors that were examined, the histologic grade of the carcinoma status was significantly related to a high risk of recurrence when analyzed using univariate (p = 0.01) and multivariate analyses (p = 0.049). Regarding survival, patients with poorly differentiated carcinomas showed a significantly unfavorable overall survival (p < 0.001), disease-specific survival (p = 0.003), and disease-free survival (p = 0.002) compared with patients with well-/moderately differentiated carcinomas according to univariate analyses. A Cox proportional hazards model indicated that a poorly differentiated carcinoma status was the only independent factor for an unfavorable overall survival (p = 0.02), disease-specific survival (p = 0.046), and disease-free survival (P = 0.04). Conclusions: Poor differentiation of tumor was the only risk factor for recurrence and an unfavorable prognosis for stage I non-small cell lung cancer patients with tumor diameters of <= 20 mm.
引用
收藏
页码:808 / 812
页数:5
相关论文
共 19 条
  • [1] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial
    Douillard, Jean-Yves
    Rosell, Rafael
    De Lena, Mario
    Carpagnano, Francesco
    Ramlau, Rodryg
    Gonzales-Larriba, Jose Luis
    Grodzki, Tornasz
    Pereira, Jose Rodrigues
    Le Groumellec, Alain
    Lorusso, Vito
    Clary, Claude
    Torres, Antonio J.
    Dahabreh, Jabrail
    Souquet, Pierre-Jean
    Astudillo, Julio
    Fournel, Pierre
    Artal-Cortes, Angel
    Jassem, Jacek
    Koubkova, Leona
    His, Patricia
    Riggi, Marcella
    Hurteloup, Patrick
    [J]. LANCET ONCOLOGY, 2006, 7 (09) : 719 - 727
  • [2] What are the clinical features of lung cancer before the diagnosis is made? - A population based case-control study
    Hamilton, W
    Peters, TJ
    Round, A
    Sharp, D
    [J]. THORAX, 2005, 60 (12) : 1059 - 1065
  • [3] PROGNOSTIC FACTORS OBTAINED BY A PATHOLOGICAL EXAMINATION IN COMPLETELY RESECTED NON-SMALL-CELL LUNG-CANCER - AN ANALYSIS IN EACH PATHOLOGICAL STAGE
    ICHINOSE, Y
    YANO, T
    ASOH, H
    YOKOYAMA, H
    YOSHINO, I
    KATSUDA, Y
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (03) : 601 - 605
  • [4] Results of surgical treatment for non-small cell lung cancer of 20 mm or less in diameter
    Iwasaki, A
    Shirakusa, T
    Yoneda, S
    Makimoto, Y
    Enatsu, S
    Hamada, T
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2004, 52 (05) : 293 - 297
  • [5] *JAP LUNG CANC SOC, 2003, GEN RUL CLIN PATH RE
  • [6] A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung
    Kato, H
    Ichinose, Y
    Ohta, M
    Hata, E
    Tsubota, N
    Tada, H
    Watanabe, Y
    Wada, H
    Tsuboi, M
    Hamajima, N
    Ohta, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (17) : 1713 - 1721
  • [7] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    Le Chevalier, T
    Arriagada, R
    Le Péchoux, C
    Grunenwald, D
    Dunant, A
    Pignon, JP
    Tarayre, M
    Abratt, R
    Arriagada, R
    Bergman, B
    Gralla, R
    Grunenwald, D
    Le Chevalier, T
    Orlowski, T
    Papadakis, E
    Pinel, MIS
    Araujo, C
    Della Torre, H
    de Solchaga, MM
    Abdi, E
    Blum, R
    Ball, D
    Basser, R
    De Boer, R
    Bishop, J
    Brigham, B
    Davis, S
    Fox, D
    Richardson, G
    Wyld, D
    Pirker, R
    Humblet, Y
    Delaunois, L
    Van Meerbeeck, JP
    Germonpre, P
    Vansteenkiste, J
    Nackaerts, K
    Pinel, MIS
    Vauthier, G
    Younes, RN
    Arriagada, R
    Baeza, R
    Carvajal, P
    Kleinman, S
    Orlandi, L
    Castro, C
    Godoy, J
    Kosatova, K
    Gaafar, R
    Azarian, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) : 351 - 360
  • [8] Revisions in the International System for Staging Lung Cancer
    Mountain, CF
    [J]. CHEST, 1997, 111 (06) : 1710 - 1717
  • [9] SURVIVAL IN EARLY-STAGE NON-SMALL-CELL LUNG-CANCER
    NESBITT, JC
    PUTNAM, JB
    WALSH, GL
    ROTH, JA
    MOUNTAIN, CF
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (02) : 466 - 472
  • [10] Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension
    Okada, M
    Sakamoto, T
    Nishio, W
    Uchino, K
    Tsubota, N
    [J]. CANCER, 2003, 98 (03) : 535 - 541